Clinical Trial Update: A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic and safety study of a fixed-dose combination tablet containing fimasartan, amlodipine, and rosuvastatin; the study has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• Fimasartan (fimasartan)
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Hypertension, Hyperlipidemia | Phase 1 | Status: COMPLETED